Category: Health

Jodhpur (Rajasthan) [India], May 12: In a step that brings traditional Ayurveda closer to modern clinical validation, Krishna’s Herbal & Ayurveda has announced the successful completion of a clinical study on its She Care Juice, designed to support women dealing with PCOD-related concerns.

For millions of women, PCOD is not just a medical term. It often shows up as irregular periods, acne, unwanted facial hair, weight gain, emotional stress, and a constant feeling that the body is out of balance. With She Care Juice, Krishna’s Ayurveda has focused on a formulation that supports women’s health naturally, while now also being backed by clinical observation.

The study was conducted as a prospective, open-label, single-arm clinical study over 90 days among women diagnosed with PCOD. The findings showed meaningful improvements across key PCOD-related symptoms. The mean mFG score, used to assess hirsutism, reduced from 11.53 to 4.88 by Day 90. Acne severity also improved significantly, with 100% of participants achieving clear or almost clear skin by the end of the study period. Participants also recorded improvements in weight, BMI, waist circumference, menstrual symptoms, and overall quality of life.

Speaking on the milestone, Mr. Shrawan Daga, Founder & CEO of Krishna’s Herbal & Ayurveda, said, “This clinical milestone is a proud moment for us. It validates our belief that Ayurveda, when backed by scientific research, can deliver safe and effective solutions for modern health challenges like PCOD. She Care Juice is not just a product, it’s a step towards holistic, root-cause wellness for women.”

The study also reported positive hormonal trends, including a decrease in the LH/FSH ratio among several participants, while metabolic markers remained stable. Importantly, no adverse events or serious adverse events were reported, and liver, kidney, thyroid, haematological parameters, and vital signs remained clinically stable throughout the study.

With this clinical milestone, Krishna’s Ayurveda aims to strengthen confidence among women looking for a natural, daily wellness support for PCOD management. The brand believes She Care Juice can become a trusted addition to a holistic routine that includes balanced nutrition, lifestyle correction, regular movement, and medical guidance wherever required.

Disclaimer: This press release is for general information purposes only and should not be construed as professional medical advice. Always consult a doctor before taking any decisions.

New Delhi [India], May 11: Every week in India, heart disease claims more than 59,000 lives. That is 350 people every hour dying in the country, accounting for 32% of all fatalities in 2023 alone, according to the Global Burden of Disease study.

These are not numbers that should surprise us anymore. And yet, the stories behind them still do.

A founder in his late 40s. A CFO who just passed his annual check-up. A senior executive whose cholesterol was “well within range.” We keep describing these events as sudden. They are not. What they are, almost without exception, is undetected. Stories like this are not unusual in India. They are, increasingly, the norm.

According to the Global Burden of Disease study (2025), 32% of all deaths in India in 2023 were caused by heart disease, or 350 every hour. More alarming is where these deaths are concentrated: urban, working-age professionals, with cardiac events now occurring almost a decade earlier in India than global averages. Many had no prior diagnosis. Several had normal reports.

The question a growing number of specialists are asking is not why these events happen. It is why they keep going undetected until it is too late.

The Gap Nobody Talks About

Ankur Bhatia spent over two decades in corporate leadership before he began asking that question seriously. What he observed — in colleagues, in peers, in the broader pattern of high-achievers who deteriorated quietly eventually led him away from the boardroom and toward a five-year deep dive into preventive cardiology, nutrition, lifestyle medicine, and the science of early risk detection.

In 2025, he founded The Pivot Health, a precision preventive health venture built around a single conviction: that the window between early biological dysfunction and an irreversible heart event is both measurable and actionable, and that the medical system, through no fault of its own, is structurally not designed for it.

“Most heart attacks are not sudden events. They are the result of years of silent accumulation. The body signals long before it breaks down. The tragedy is that we have built a system that only listens once something has already gone wrong.” — Ankur Bhatia, Founder, The Pivot Health

The problem, Ankur argues, is not that people are not getting check-ups. It is that the check-ups are asking the wrong questions. A standard lipid panel measures total cholesterol. It does not measure ApoB — the particle most directly linked to arterial damage. It does not screen for Lipoprotein(a), a genetically inherited risk factor present in roughly one in five people and entirely absent from routine diagnostics. It does not assess fasting insulin, which can help identify diabetes, which is one of the risk factors for heart problems, or high-sensitivity CRP, which is a marker of silent inflammation in the body, which means plaque formation is accelerated, and also the probability of a heart attack. 

“Two people can walk out of the same clinic with the same cholesterol reading,” Ankur explains, “and be carrying completely different levels of risk. Standard diagnostics cannot tell you which one is which. That is the gap we are working in.”

The Pivot Health’s approach — built around what Ankur calls the Detect, Decode, Reverse methodology — begins with a deep diagnostic assessment across eight health dimensions, including metabolic function, inflammatory status, body composition, hormonal balance, and cardiovascular fitness. The goal is not to identify disease. It is to identify the conditions under which the disease is quietly forming. Programmes are then built entirely around the individual — their biology, their schedule, their specific risk drivers — combining evidence-based nutrition, structured movement, stress regulation, and modern health technology to track and shift the markers that matter most.

Pivot – Treating the Root, Not the Readout

What distinguishes the more effective approaches emerging in this space is not the technology or the test panel — it is the starting question. Rather than asking “what disease does this person have,” the question becomes “what is this person’s body moving toward, and how fast.” programme at The Pivot Health is built on that distinction — assessing health across multiple dimensions simultaneously, identifying the one or two root drivers creating the most risk, and building an intervention precise enough to fit inside a demanding professional life rather than disrupting it

A Shift That Cannot Come Fast Enough

India’s burden of cardiovascular disease is not simply a healthcare problem. It is an economic one. The demographic most at risk, urban professionals between 40 and 55, represents the country’s most productive working population. The cost of losing them, or of managing their decline through years of medication and repeated hospitalisation, is one that corporations, insurers, and families are already absorbing without fully understanding its source.

There are signs of change. Awareness of preventive health is growing. A small but expanding cohort of physicians, insurers, and corporate health buyers is beginning to look beyond the annual check-up toward programmes that offer genuine risk modification rather than routine reassurance. But specialists in the field caution that the pace remains slow relative to the scale of the problem.

For Ankur, the urgency is personal as much as professional. “I built this because I watched people I respected fall apart in slow motion, and nobody caught it in time,” he says. “The data was always there. The tests to read it exist. What has been missing is the framework to put it together — and the willingness to intervene before the crisis, not after.”

In the case of heart disease, what is missed early cannot always be fixed later.

Pivot Health offers personalised preventive programmes for business leaders, Founders, and senior professionals. www.thepivothealth.com

Disclaimer: This press release is for general information purposes only and should not be construed as professional medical advice. Always consult a doctor before taking any decisions.

Retinoblastoma in Children: Why Early Detection Matters More Than Most Parents Realise

New Delhi [India], April 30: Most parents never expect a family photo to raise a medical concern. But for some parents, that is exactly what happens. The camera flash catches something different, one eye glows red as it should, and the other shows a strange white or pale reflection. Easy to dismiss as a glitch. Easy to scroll past.

For many children, that white glow in the eye is the first visible sign that something is wrong inside the eye.

Retinoblastoma is not a condition most people grow up knowing about. It is rare. But it is the most common eye cancer seen in young children, and the families who have been through it will tell you the same thing: they wish they had known sooner. Because the earlier it is caught, the more options a family has, and the better the chances of saving both the child’s vision and their life.

ASG Eye Hospital has made it a priority to change that. Not just by treating the condition, but by making sure more parents, more doctors, and more communities know what retinoblastoma is and how to identify it before it becomes serious.

Understanding Retinoblastoma and Who It Affects

Retinoblastoma starts in the retina, the thin layer at the back of the eye that processes light and sends signals to the brain. In young children, certain cells in the retina can begin dividing uncontrollably, forming a tumour. It sounds complicated, but the biology matters less than this simple fact: it grows fast, and it responds well to treatment when it has not spread far.

Retinoblastoma almost always affects children under five. Some cases run in families, passed down through a gene mutation. In those situations, both eyes can be affected, and siblings or future children may carry the same risk.

A parent with a family history of retinoblastoma should not wait for symptoms. Screening can begin at birth.

One of the most common questions doctors hear is whether retinoblastoma can be cured. In many cases, yes, particularly when it is found while still confined to the eye.

Early Signs of Retinoblastoma That Parents Should Know

Children rarely complain about their vision changing. They do not know what they are supposed to see. So the early signs of retinoblastoma tend to be spotted by someone watching, a parent, a grandparent, a nursery teacher, or a paediatrician doing a routine check.

The sign that gets noticed most often is a white or yellowish glow in the pupil. In medical terms, it is called leukocoria. In everyday life, it shows up most clearly in flash photographs, where one eye catches the light differently from the other. In person, under normal lighting, it can be almost invisible, which is why so many families recall noticing it first in a photo rather than face-to-face.

Beyond that, other changes that may point to a problem include:

• One eye turning inward or outward, or appearing misaligned
• Persistent redness or visible swelling around the eye
• A shift in the colour of the iris
• A child rubbing or closing one eye more than usual
• Older children mentioning they cannot see properly from one side

One important thing to understand: retinoblastoma does not usually hurt. A child can have a growing tumour and show no signs of discomfort at all. That silence is part of what makes it easy to miss.

Eye Cancer in Children: Symptoms | What to Look for in Photographs

It might sound like an overstatement, but a mobile phone camera has genuinely helped catch retinoblastoma in children before a doctor ever got the chance to look.

Eye cancer in children often shows up in photographs long before they become obvious in daily life. The white reflex in child’s eye, leukocoria, happens because the tumour reflects light back through the pupil in a way healthy retinal tissue does not. With flash photography, that reflection can be quite stark.

Families describe noticing it at birthday parties, in holiday videos, in a random selfie taken on a Sunday afternoon. Some noticed it across several photos spanning months and convinced themselves it was just the camera angle.

If one eye consistently shows a pale or white reflection in flash photos, while the other shows the usual red-eye, that is worth taking seriously. It does not mean something is definitely wrong. But it does mean a specialist should take a look.

Pediatric Eye Cancer Diagnosis: How It Is Confirmed

When a child is brought in with a suspected eye problem, the examination needs to be thorough and with very young children, that usually means doing it under general anaesthesia. A toddler cannot be asked to stay still and look in a particular direction for the time it takes to properly examine the retina.

The ophthalmologist uses a specialised indirect ophthalmoscope to view the back of the eye in detail. If a tumour is present, its location, size, and spread are assessed. Ultrasound imaging can help map the extent of what is inside the eye. An MRI is used to check whether anything has spread beyond it.

A concern that comes up almost every time is whether the child will lose the eye. Understandably so. But the honest answer is that it depends almost entirely on when the diagnosis happens. Caught early, the eye can very often be saved. Caught late, the priority shifts to saving the child’s life.

At ASG Eye Hospital, paediatric eye examinations are carried out in a setting designed with young patients in mind, because a child who is calm and comfortable makes for a far more accurate assessment.

Retinoblastoma Treatment in India: What the Process Involves

Retinoblastoma treatment in India has come a long way. Families in cities across the country now have access to approaches that, not long ago, were only available at a handful of specialised centres abroad.

Treatment is never one-size-fits-all. It is built around how far the tumour has progressed, whether one eye or both are involved, and what is most likely to preserve vision while eliminating the cancer. The options commonly used include:

• Chemotherapy – given either through a vein or directly into the artery supplying the eye, to shrink the tumour before other treatments are applied
• Laser therapy or cryotherapy – used to target and destroy smaller tumours with precision
• Radiation therapy – considered in specific cases where other approaches are not sufficient
• Surgical removal of the eye – only when the tumour is at an advanced stage, and saving the eye is no longer a safe option

These treatments rarely happen in isolation. An oncologist, a paediatric ophthalmologist, and sometimes a radiation specialist work together to build a plan specific to each child.

Parents often want to know what vision will look like after treatment. Where the eye is preserved, and the response to treatment is good, useful vision is often maintained. But it is not guaranteed, and it depends heavily on where in the retina the tumour was sitting.

The Role of Routine Eye Checks in Children

A red reflex test takes about ten seconds. A paediatrician shines a light into a child’s eyes during a routine visit and checks that the reflection looks the same in both. If one eye shows a white or dull reflex instead of the expected red, that child gets referred to a specialist.

That one check, done at every well-child visit, is one of the most reliable ways to catch retinoblastoma early.

For children born into families with a known history of the condition, the process goes further. Genetic counselling, testing, and regular eye examinations under anaesthesia may begin from the first weeks of life.

ASG Eye Hospital actively supports retinoblastoma awareness among paediatricians and general practitioners, because a lot of retinoblastoma cases are first seen not in an eye clinic, but in a general practitioner’s consulting room. The sooner that referral happens, the better the outcome tends to be.

Why Early Detection Changes Everything

The gap between an early diagnosis and a late one can mean the difference between a child keeping their eye and losing it. In some cases, it is the difference between a localised tumour and one that has spread beyond the eye entirely.

Children whose retinoblastoma is diagnosed while still small and contained have the strongest outcomes, both for survival and for sight. Those who reach a specialist after months of unnoticed progression face harder choices and fewer options.

There is no sophisticated test required to start that process. It begins with a parent knowing what a white reflex in child eye looks like in a photograph. It begins with a General Practitioner who refers rather than waits. It begins with communities talking openly about retinoblastoma, because it is rare and tends to stay in the shadows.

ASG Eye Hospital, with centres across Jodhpur, Mumbai, Delhi, Jaipur, Pune, Guwahati, and more, is working to make sure that retinoblastoma awareness reaches every corner of the country, because every child deserves to be seen clearly and seen in time.

FAQs

1. What Are the Most Common Retinoblastoma Symptoms in Children? 
 The most frequently noticed sign is a white or pale glow in one eye, particularly visible in flash photographs. A squint, persistent redness, or a change in eye colour can also be early indicators worth checking out.

2. What Causes the White Reflex in a Child’s Eye?

The tumour sits inside the retina and reflects light through the pupil. Instead of the normal red reflex seen in photos, the affected eye shows white or yellow, a sign that something is different at the back of the eye.

3. At What Age Does Retinoblastoma Usually Develop? 
 
 The majority of cases are diagnosed in children under five. It becomes significantly less common as children get older and is rarely seen in adults.

4. Is Retinoblastoma Treatable in India? 
 
 Yes. Access to specialised paediatric eye cancer diagnosis and treatment has improved considerably across India. When found early, outcomes are genuinely encouraging.

5. Should All Children Be Screened for Retinoblastoma? 
 
 A basic red reflex check at routine paediatric visits is something every child should have. For those with a family history of the condition, more thorough and frequent screening from birth is strongly recommended.

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

Retinoblastoma in Children: Why Early Detection Matters More Than Most Parents Realise

New Delhi [India], April 30: Most parents never expect a family photo to raise a medical concern. But for some parents, that is exactly what happens. The camera flash catches something different, one eye glows red as it should, and the other shows a strange white or pale reflection. Easy to dismiss as a glitch. Easy to scroll past.

For many children, that white glow in the eye is the first visible sign that something is wrong inside the eye.

Retinoblastoma is not a condition most people grow up knowing about. It is rare. But it is the most common eye cancer seen in young children, and the families who have been through it will tell you the same thing: they wish they had known sooner. Because the earlier it is caught, the more options a family has, and the better the chances of saving both the child’s vision and their life.

ASG Eye Hospital has made it a priority to change that. Not just by treating the condition, but by making sure more parents, more doctors, and more communities know what retinoblastoma is and how to identify it before it becomes serious.

Understanding Retinoblastoma and Who It Affects

Retinoblastoma starts in the retina, the thin layer at the back of the eye that processes light and sends signals to the brain. In young children, certain cells in the retina can begin dividing uncontrollably, forming a tumour. It sounds complicated, but the biology matters less than this simple fact: it grows fast, and it responds well to treatment when it has not spread far.

Retinoblastoma almost always affects children under five. Some cases run in families, passed down through a gene mutation. In those situations, both eyes can be affected, and siblings or future children may carry the same risk.

A parent with a family history of retinoblastoma should not wait for symptoms. Screening can begin at birth.

One of the most common questions doctors hear is whether retinoblastoma can be cured. In many cases, yes, particularly when it is found while still confined to the eye.

Early Signs of Retinoblastoma That Parents Should Know

Children rarely complain about their vision changing. They do not know what they are supposed to see. So the early signs of retinoblastoma tend to be spotted by someone watching, a parent, a grandparent, a nursery teacher, or a paediatrician doing a routine check.

The sign that gets noticed most often is a white or yellowish glow in the pupil. In medical terms, it is called leukocoria. In everyday life, it shows up most clearly in flash photographs, where one eye catches the light differently from the other. In person, under normal lighting, it can be almost invisible, which is why so many families recall noticing it first in a photo rather than face-to-face.

Beyond that, other changes that may point to a problem include:

• One eye turning inward or outward, or appearing misaligned
• Persistent redness or visible swelling around the eye
• A shift in the colour of the iris
• A child rubbing or closing one eye more than usual
• Older children mentioning they cannot see properly from one side

One important thing to understand: retinoblastoma does not usually hurt. A child can have a growing tumour and show no signs of discomfort at all. That silence is part of what makes it easy to miss.

Eye Cancer in Children: Symptoms | What to Look for in Photographs

It might sound like an overstatement, but a mobile phone camera has genuinely helped catch retinoblastoma in children before a doctor ever got the chance to look.

Eye cancer in children often shows up in photographs long before they become obvious in daily life. The white reflex in child’s eye, leukocoria, happens because the tumour reflects light back through the pupil in a way healthy retinal tissue does not. With flash photography, that reflection can be quite stark.

Families describe noticing it at birthday parties, in holiday videos, in a random selfie taken on a Sunday afternoon. Some noticed it across several photos spanning months and convinced themselves it was just the camera angle.

If one eye consistently shows a pale or white reflection in flash photos, while the other shows the usual red-eye, that is worth taking seriously. It does not mean something is definitely wrong. But it does mean a specialist should take a look.

Pediatric Eye Cancer Diagnosis: How It Is Confirmed

When a child is brought in with a suspected eye problem, the examination needs to be thorough and with very young children, that usually means doing it under general anaesthesia. A toddler cannot be asked to stay still and look in a particular direction for the time it takes to properly examine the retina.

The ophthalmologist uses a specialised indirect ophthalmoscope to view the back of the eye in detail. If a tumour is present, its location, size, and spread are assessed. Ultrasound imaging can help map the extent of what is inside the eye. An MRI is used to check whether anything has spread beyond it.

A concern that comes up almost every time is whether the child will lose the eye. Understandably so. But the honest answer is that it depends almost entirely on when the diagnosis happens. Caught early, the eye can very often be saved. Caught late, the priority shifts to saving the child’s life.

At ASG Eye Hospital, paediatric eye examinations are carried out in a setting designed with young patients in mind, because a child who is calm and comfortable makes for a far more accurate assessment.

Retinoblastoma Treatment in India: What the Process Involves

Retinoblastoma treatment in India has come a long way. Families in cities across the country now have access to approaches that, not long ago, were only available at a handful of specialised centres abroad.

Treatment is never one-size-fits-all. It is built around how far the tumour has progressed, whether one eye or both are involved, and what is most likely to preserve vision while eliminating the cancer. The options commonly used include:

• Chemotherapy – given either through a vein or directly into the artery supplying the eye, to shrink the tumour before other treatments are applied
• Laser therapy or cryotherapy – used to target and destroy smaller tumours with precision
• Radiation therapy – considered in specific cases where other approaches are not sufficient
• Surgical removal of the eye – only when the tumour is at an advanced stage, and saving the eye is no longer a safe option

These treatments rarely happen in isolation. An oncologist, a paediatric ophthalmologist, and sometimes a radiation specialist work together to build a plan specific to each child.

Parents often want to know what vision will look like after treatment. Where the eye is preserved, and the response to treatment is good, useful vision is often maintained. But it is not guaranteed, and it depends heavily on where in the retina the tumour was sitting.

The Role of Routine Eye Checks in Children

A red reflex test takes about ten seconds. A paediatrician shines a light into a child’s eyes during a routine visit and checks that the reflection looks the same in both. If one eye shows a white or dull reflex instead of the expected red, that child gets referred to a specialist.

That one check, done at every well-child visit, is one of the most reliable ways to catch retinoblastoma early.

For children born into families with a known history of the condition, the process goes further. Genetic counselling, testing, and regular eye examinations under anaesthesia may begin from the first weeks of life.

ASG Eye Hospital actively supports retinoblastoma awareness among paediatricians and general practitioners, because a lot of retinoblastoma cases are first seen not in an eye clinic, but in a general practitioner’s consulting room. The sooner that referral happens, the better the outcome tends to be.

Why Early Detection Changes Everything

The gap between an early diagnosis and a late one can mean the difference between a child keeping their eye and losing it. In some cases, it is the difference between a localised tumour and one that has spread beyond the eye entirely.

Children whose retinoblastoma is diagnosed while still small and contained have the strongest outcomes, both for survival and for sight. Those who reach a specialist after months of unnoticed progression face harder choices and fewer options.

There is no sophisticated test required to start that process. It begins with a parent knowing what a white reflex in child eye looks like in a photograph. It begins with a General Practitioner who refers rather than waits. It begins with communities talking openly about retinoblastoma, because it is rare and tends to stay in the shadows.

ASG Eye Hospital, with centres across Jodhpur, Mumbai, Delhi, Jaipur, Pune, Guwahati, and more, is working to make sure that retinoblastoma awareness reaches every corner of the country, because every child deserves to be seen clearly and seen in time.

FAQs

1. What Are the Most Common Retinoblastoma Symptoms in Children? 
 The most frequently noticed sign is a white or pale glow in one eye, particularly visible in flash photographs. A squint, persistent redness, or a change in eye colour can also be early indicators worth checking out.

2. What Causes the White Reflex in a Child’s Eye?

The tumour sits inside the retina and reflects light through the pupil. Instead of the normal red reflex seen in photos, the affected eye shows white or yellow, a sign that something is different at the back of the eye.

3. At What Age Does Retinoblastoma Usually Develop? 
 
 The majority of cases are diagnosed in children under five. It becomes significantly less common as children get older and is rarely seen in adults.

4. Is Retinoblastoma Treatable in India? 
 
 Yes. Access to specialised paediatric eye cancer diagnosis and treatment has improved considerably across India. When found early, outcomes are genuinely encouraging.

5. Should All Children Be Screened for Retinoblastoma? 
 
 A basic red reflex check at routine paediatric visits is something every child should have. For those with a family history of the condition, more thorough and frequent screening from birth is strongly recommended.

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

New Delhi [India], April 27: The preventive healthcare segment in India is witnessing steady growth, and global nutraceutical brands are increasingly looking at the country as a key market. Tapping into this momentum, Nature’s Way Alive, a widely recognised US-based nutraceutical brand, has officially entered the Indian market.

The brand is being introduced in India by Dr. Willmar Schwabe India Pvt. Ltd., a part of the globally established Schwabe Group. With a strong legacy in herbal and natural medicine, the group aims to strengthen its presence in the country’s expanding wellness and dietary supplement category through this launch.

The Schwabe Group traces its origins to 1866, when German pharmacist Dr. Willmar Schwabe established pharmaceutical quality standards in homeopathy and herbal medicine. Over the decades, the company has grown into a global name in phytopharmaceuticals and homeopathy, recognised for its focus on research, quality control and herbal extract expertise.

The India launch of Nature’s Way Alive comes at a time when concerns around nutrient deficiencies are becoming more visible in urban populations. Several studies indicate that a significant proportion of adults in urban India experience deficiencies in essential nutrients. Besides deficiencies in Vitamin B12 and Iron, Vitamin D deficiency affects 40%¹ of urban youth; and 60%¹ of the overall urban population suffers from Calcium deficiency. 

Lifestyle changes are a key contributing factor: long working hours, irregular meal patterns, increasing reliance on processed foods, and rising stress levels. However, consumer awareness around preventive health has also grown alongside. This has prompted the demand for plant-based, food-derived supplements to balance diets and support long-term wellness. Nature’s Way Alive aims to address this demand by offering food-based nutritional supplements derived from fruits, vegetables and herbal extracts, for which it is also known globally. 

Their initial product portfolio for India includes a range of wellness supplements for adults and kids alike:

• Men’s Multivitamin – Supports energy, immunity, and overall vitality.
• Women’s Multivitamin – Designed for energy, bone health, and daily nutritional balance.
• Omega-3 – Supports heart, brain, and joint health.
• Calcium Bone Support – Promotes bone strength and density.
• Single Herb Supplements – Targeted herbal wellness solutions.
• CoQ10 – Daily essential for heart health to combat cellular fatigue.
• Kids Tummy Soothe – Child-friendly digestive support against nausea, indigestion, and gas.

According to Mr. Ashish Kumar, EVP – APAC, Schwabe Group, the launch reflects the company’s commitment to making trusted natural healthcare solutions more widely available. 

“Consumers today are increasingly conscious about maintaining their health through preventive measures. There is a clear shift towards natural, plant-based supplements that can support everyday nutrition,” he said. “With Nature’s Way Alive, we are bringing globally recognised, food-based nutrition supported by US ideology and German quality standards to Indian consumers complying the local regulation. Our focus is to bridge the daily nutrient gaps while also encouraging individuals to have a proactive approach to overall well-being.”

Industry observers note that India’s nutraceutical market has been expanding rapidly, driven by rising health awareness, lifestyle changes and growing interest in preventive healthcare solutions. To summarise, Indian consumers want reliable nutritional options for everyday health. This positions the Nature’s Way Alive launch as a major step forward in aiding Schwabe Group’s growth in the evolving Indian wellness landscape in 2026 and beyond. 

To learn more about Nature’s Way Alive, its mission, and products, visit https://www.natureswayalive.com/ 

*This is only a trademark and does not represent its true nature.

Nature’s Way Alive! combines the power of nature and advanced nutrition to create premium multivitamins and supplements for modern lifestyles with nutrient-dense formulas. With vibrant blends of fruits and vegetables, herbs, and extracts, the brand is committed to supporting energy, immunity, and overall vitality, helping people feel alive every day. 

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

New Delhi [India], April 25: A bare or patchy scalp not only impacts one’s look but also self-esteem and personality. Due to the long-term impact of baldness on personal and professional life, the demand for permanent hair restoration has reached an all-time high. Over the years, New Delhi has cemented its position as a hair restoration hub with people from across the country and abroad coming here for hair transplant procedures. However, with a surge in providers, patients often find themselves overwhelmed by choices. While the market is saturated with options, the difference between a life-changing transformation and a medical complication lies in the selection process. To address this, here is a comprehensive guide to help people choose the best hair transplant clinic in Delhi NCR.

Choosing Expertise over Everything

When selecting a hair transplant clinic in Delhi, the patient should give utmost importance to the surgeon. Hair transplant is an art rather than a surgery. It requires knowledge of facial symmetry, graft angulation, and donor management. Dr. Navnit Haror, founder of Dr. Haror’s Wellness, who has pioneered the Ultra Receptive Hair Transplant technique, says that it is the “who” that matters more than the “where.”

Being a Gold Medalist Dermatologist and international hair transplant surgeon with 17+ years of experience, he believes that a hair transplant is a lifelong change to one’s appearance, so there can be no room for any mistakes, no universal approach. Patients must look for a surgeon who has both clinical precision and an artistic eye. He further says that, “From my first surgery to recent, my aim has always been to make sure that the hairline we make today looks natural even after twenty years.” 

Deciphering the Technique

The evolution of hair restoration has moved beyond the outdated, painful methods of the past. Today, the technique used determines the recovery time and the density of the final look. Whether it is the advanced FUE (Follicular Unit Extraction) or specialized Ultra Receptive Hair Transplant, the hair transplant clinic in Delhi must offer a customized plan tailored to the patient’s specific grade of baldness.

“Innovation should never come at the cost of safety,” notes Dr. Haror. “We utilize the latest international protocols to ensure maximum graft survival rates. By integrating cutting-edge hair transplant techniques with meticulous graft handling, we can achieve results that are virtually indistinguishable from natural hair growth.“

Balancing Cost and Value

Hair transplant cost in Delhi NCR is one of the main issues for many people. However, hair transplant experts caution against selecting a clinic based solely on the lowest price. “Cheap” hair transplant surgery often leads to “expensive” repair surgeries in the future. A well-established clinic maintains complete transparency about the cost without any secret charges. The investment should cover not just the surgery, but also the clinic’s environment, facilities offered, and the overall post-operative care that ensures the longevity of the results. 

The Proof is in the Results

A gallery full of successful hair transplant results is the trademark of the best hair transplant clinic in Delhi NCR. So, patients are advised to go beyond advertising and see actual hair transplant results. 

“At the end of the day, our work should do the talking through the confidence of our patients,” says Dr. Navnit Haror. He further says, “When a patient looks in the mirror and sees a fuller head of hair and a renewed sense of self, it is the real measure of a successful transplant. We don’t just move hair; we restore identities.”

Dr. Haror’s Wellness – The Best Hair Transplant Clinic in Delhi 

Dr. Haror’s Wellness, located in the heart of the National Capital, is an aesthetic hub for those who want to experience world-class hair restoration and aesthetic treatment. The clinic is headed by Dr. Navnit Haror, a gold medalist dermatologist, and Dr. Vineeta Pathak, cosmetologist & aesthetic physician. The clinic is known for ethics, patient safety, and international standards. Their treatment philosophy is based on the idea that each patient should get a unique experience. The entire process, starting with the first consultation, where the doctor carries out a comprehensive scalp analysis, up to the final follow-up, is managed with the highest professionalism.

If you are dealing with permanent hair loss and searching for the best hair transplant clinic in Delhi NCR, Dr. Haror’s Wellness should be at the top of your list. Their focus on the latest techniques to deliver world-class results at competitive costs makes them the favorite among celebrities, professionals, and international patients.  Schedule your consultation today to experience excellence in hair restoration. Under the expert guidance of Dr. Navnit Haror, a Gold Medalist Dermatologist and international hair transplant surgeon, your journey to a fuller head of hair is in the safest possible hands.

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

London [United Kingdom], April 25: At the Charing Cross Symposium 2026 this week, one theme kept resurfacing in quiet conversations between clinicians: what happens after the first year?

It’s a question that doesn’t always make headlines, but it tends to shape real-world decisions. The preliminary three-year data from the SIRONA randomised trial, presented by Prof. Ulf Teichgräber, leaned directly into that gap.

The study, backed by Concept Medical Inc., compares sirolimus-coated and paclitaxel-coated balloon angioplasty in femoropopliteal artery disease — an area where treatment choices have long been influenced by familiarity as much as by evidence.

Looking Past the First Milestone

For years, most discussions around drug-coated balloons have centred on JACC 6- or 12-month results. Those numbers are important, but they don’t always tell the full story.

SIRONA was set up to follow that story a little longer.

The trial had already reported its one-year findings in the Journal of the American College of Cardiology, where the sirolimus-coated approach held its ground against paclitaxel across key endpoints. What’s different now is the added perspective of time.

What the Data Is Beginning to Show

At three years, the gap that’s starting to draw attention is reintervention.

Patients treated with the sirolimus-coated balloon showed a higher rate of freedom from clinically driven target lesion revascularisation. In simpler terms, fewer of them needed to come back for another procedure.

The rest of the data is, in some ways, just as important for what it doesn’t reveal. Mortality rates stayed aligned between the two groups. Major amputations remained rare. No unexpected safety signals appeared.

It’s not the kind of data that shouts. It’s the kind that settles in slowly.

Measured Optimism from the Clinical Side

Prof. Ulf Teichgräber, who presented the findings, didn’t overstate the outcome. His view was straightforward; the consistency over three years is encouraging, particularly in a setting where durability is often hard to demonstrate.

At the same time, he drew a clear line around interpretation. Not all sirolimus-coated balloons are the same, and results from one platform shouldn’t automatically be extended to others. It’s a reminder that device-specific data still matters.

Where Concept Medical Fits In

For Dr. Manish Doshi, the SIRONA trial reflects a longer game.

There’s an obvious commercial angle to any clinical programme, but in this case, the emphasis has been on building a dataset that extends beyond early reassurance. The company has leaned into longer follow-ups at a time when the market itself is starting to demand them.

As Concept Medical Inc. expands into more geographies, that kind of data may end up carrying more weight than initial performance claims.

A Subtle Shift in the Field

Nothing about the SIRONA update suggests an overnight change in practice. That’s not how this space works.

What it does suggest is a shift in what people are paying attention to.

There’s a growing sense that durability — not just immediate success — is becoming the more relevant benchmark. And studies that can hold up over time are starting to stand out.

If the final adjudicated results align with what’s been presented so far, the conversation around sirolimus-coated balloons could move from “alternative option” to something closer to a standard consideration.

For now, though, it remains what it is, an early but steady signal, and one that the field seems to be watching a little more closely.

Launch aligns with rising fatty liver prevalence and a rapidly expanding nutraceutical market, reinforcing the Company’s strategy to build condition-led preventive healthcare categories.

Mumbai (Maharashtra) [India], April 24: In a continued effort to expand its preventive healthcare portfolio, Aayush Wellness Limited (BSE: 539528,  MSEI:  AAYUSH),  an Integrated Healthcare company, has announced the launch of its latest innovation, Liver Care Tablets. This advanced herbal formulation is designed to naturally detoxify, protect, and regenerate liver cells, addressing the growing liver health challenges triggered by modern lifestyle habits, environmental toxins, and poor dietary choices.

The launch strengthens Aayush Wellness Limited’s expanding preventive healthcare portfolio and positions the company to participate in a large and growing wellness opportunity driven by lifestyle disorders, rising health awareness, and increasing consumer preference for daily condition-support products.

Liver health is emerging as a major public health and preventive care theme in India. Government and clinical sources note that chronic liver disease in India is driven by non-alcoholic fatty liver disease, alcohol-related liver disease, and viral hepatitis, while official data cited in Parliament referenced that over 200,000 deaths annually in India are attributed to liver diseases, making it the 10th most common cause of death.

Fatty liver disease, in particular, is becoming a significant metabolic health concern. Recent estimates cited by health reporting indicate prevalence in India may range from 9% to 53%, and one multicity cohort reported evidence of fatty liver in about 38.9% of adults screened, highlighting a large underserved need for early, preventive liver-support solutions.

Against this backdrop, Aayush Wellness Limited’s Liver Detox Tablets are designed to address a growing consumer need for proactive liver support before disease progression and more serious complications emerge.

The formulation combines Milk Thistle, N-Acetyl Cysteine (NAC), Alpha Lipoic Acid, and L-Glutamine, ingredients selected to support detoxification pathways, help reduce oxidative stress, promote liver cell protection, and support metabolic balance.

For investors, the launch reflects Aayush Wellness Limited’s strategy of building a diversified preventive wellness portfolio around high-relevance, repeat-use categories shaped by modern lifestyle risks. The company’s recent product expansion across Herbal Masala, Beauty Gummies, Sleep Gummies, Lung Care Tablets, and now Liver Care Tablets demonstrates a scalable platform approach to consumer healthcare innovation.

India’s nutraceutical market, currently estimated at approximately $18 billion, is witnessing strong double-digit growth, supported by rising health awareness, increasing disposable incomes, and a shift toward preventive healthcare. Within this context, Aayush Wellness Limited is strategically positioning itself to capture emerging opportunities by expanding its product range and strengthening its presence in high-growth wellness categories.

Commenting on the launch, Naveenakumar, Managing Director of Aayush Wellness Limited, said:

“Liver health remains an under-addressed yet critical component of overall well-being. With our Liver Care Tablets, we aim to offer a preventive solution that empowers individuals to proactively manage their health. By integrating Ayurvedic wisdom with clinically validated ingredients, we are building solutions that are both effective and aligned with evolving consumer preferences.”

With a focus on innovation, quality, and accessibility, the company continues to invest in research-driven product development and consumer-centric solutions. The launch of Liver Detox Tablets is expected to enhance Aayush Wellness Limited’s market positioning while contributing to long-term value creation for stakeholders by tapping into the rapidly growing preventive healthcare segment.

Liver Detox Tablets are available for purchase on our official website at store.aayushwellness.com/ and will soon be accessible across leading online marketplaces.

About Aayush Wellness Limited:

(ISO 9000 and 22000 certified company)

Aayush Wellness Limited [BSE scrip code: 539528, MSEI Symbol – AAYUSH], established in 1984, is a pioneering name in health and wellness solutions, dedicated to offering products that merge wellbeing with innovation. We are India’s integrated healthcare company committed to offering quality products and services to enhance the consumer well-being. Aayush Wellness continues to lead the industry in promoting healthier lifestyle choices through its diverse range of wellness products and services. For more information, please visit www.aayushwellness.com or Call 8655611700 for business inquiries.

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

Mumbai (Maharashtra) [India], April 23: DR. Rashel, one of India’s leading skincare brands, successfully hosted The Sun & Skin Affair in Mumbai — an exclusive, invitation-only event that brought together over 200 creators and influencers for a high-energy, summer-inspired poolside celebration.

Built around the brand’s vibrant summer campaign, “Karo Dhoop Se Dosti”, the event highlighted the rising popularity of DR.Rashel’s customer-favourite De-Tan range, with the De-Tan Sunscreen and De-Tan Scrub emerging as category bestsellers across e-commerce platforms like Amazon and Flipkart. The campaign motivates consumers to adopt an effective summer skincare routine that helps protect, heal, and improve the skin, encouraging them to embrace the sun with confidence while staying protected.

The evening was elevated by the presence of Bollywood icon Raveena Tandon and social media sensation Avneet Kaur, who added star power and excitement to the already buzzing atmosphere. From poolside experiences to interactive brand moments, the event delivered an unforgettable blend of skincare, entertainment, and summer vibes.

Interacting with the media, Avneet Kaur shared her love for the De-Tan Sunscreen, highlighting that it is a 100% vegan and Made-in-India formulation, making it a perfect fit for her summer skincare routine.

Raveena Tandon, while sharing her summer skincare hacks, also praised the event for its vibrant concept and energy. She expressed her admiration for DR.Rashel, saying, “I love the brand, and I will always be one of its strongest supporters.”

The event brought together a thoughtfully curated mix of experiences—from a DIY Charm Studio and a dedicated product experience centre to engaging games that kept the vibe alive all evening. Guests indulged in curated food and refreshing beverages, all set to music that seamlessly tied the entire poolside experience together.

Speaking about the event, co-founder Pravin Bera said,
 “At DR.Rashel, we believe skincare should be simple, effective, and enjoyable. ‘Karo Dhoop Se Dosti’ is not just a campaign — it’s a mindset shift. Through this event, we wanted to create an experience that reflects our philosophy and connects with our audience in a fun, meaningful way.”

Co-founder Devji Hathiyani added,
 “The Sun & Skin Affair is a celebration of our community — the creators, consumers, and partners who have been a part of our journey. Seeing such an overwhelming response motivates us to continue innovating and delivering products that truly resonate with Indian consumers.”

With The Sun & Skin Affair, DR.Rashel proved once again that it goes beyond skincare — creating experiences, building communities, and living its philosophy of “Life is BeYOUtiful.”

About DR.Rashel

 DR.Rashel is a leading beauty and personal care brand committed to delivering innovative, high-performance skincare solutions. Backed by a diverse product portfolio and a strong omnichannel presence, the brand blends global skincare trends with formulations suited for Indian skin, making it a trusted choice among millions of consumers.

Website: https://dr.rashel.in

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

Mumbai (Maharashtra) [India], April 23: Unihealth Hospitals Limited (NSE: UNIHEALTH | INE0PRF01011) a leading integrated healthcare services provider in India and East Africa, today announced the successful acquisition and commissioning of UMC Hospital, Entebbe. 

This strategic expansion adds 30 beds to the network, increasing the total bed capacity of the Company in Uganda to 150 beds and reinforcing UniHealth’s commitment to delivering high-quality, accessible healthcare services across the country.

Located in a key catchment area, UMC Hospital, Entebbe, will operate as a critical extension of UniHealth’s flagship facility in Kampala, UMC Victoria Hospital. The expansion enhances UniHealth’s ability to serve both urban and peri-urban populations, easing capacity constraints and improving patient access to specialized and tertiary care services.

With the commissioning of the upgraded facility, UMC Hospital, Entebbe will offer an expanded range of services across faculties, including Internal Medicine, General Surgery, Obstetrics and Gynaecology, Paediatrics, Orthopaedics and Trauma Management, Chronic Disease Management Programs, and comprehensive Diagnostic and Laboratory Services.

The facility will support outpatient services, inpatient admissions, and day-care and surgical procedures, enabling faster patient throughput and improved clinical outcomes.

The addition of UMC Hospital, Entebbe, strengthens UniHealth’s hub-and-spoke model, with UMC Victoria Hospital serving as the central hub for complex, high-acuity cases, while Entebbe operates as a high-quality spoke facility for primary, secondary, and select tertiary services.

This integrated model delivers several key advantages:

• Optimized Resource Utilization: Efficient allocation of medical expertise and infrastructure across facilities
• Improved Patient Flow: Seamless referrals between Entebbe and Kampala for specialized interventions
• Reduced Wait Times: Decongestion at the flagship hospital, enhancing patient experience
• Enhanced Clinical Outcomes: Coordinated care pathways across the network

The commissioning of UMC Hospital, Entebbe, is expected to be accretive to UniHealth’s financial performance. 

By expanding capacity and service offerings, the Company anticipates:

• Increased patient volumes across both inpatient and outpatient segments
• Higher occupancy rates driven by improved accessibility
• Enhanced case mix with greater contribution from specialized procedures
• Improved operating margins through economies of scale and shared services

The hub-and-spoke model is designed to drive operational efficiencies, reduce duplication of high-cost assets, and optimize clinician productivity, supporting sustainable margin expansion over the medium term.

Commenting on the development, Dr. Anurag Shah, Founder and Director of Unihealth Hospitals Limited, said, “This expansion marks a significant milestone in our journey to build a robust, integrated healthcare network in Uganda. UMC Hospital, Entebbe, will play a pivotal role in extending quality care closer to communities while strengthening our flagship operations in Kampala. We believe this initiative will not only enhance patient outcomes but also create meaningful value for our stakeholders through improved efficiencies and growth.”

Adding to this, Dr. Akshay Parmar, Founder and Managing Director of Unihealth Hospitals Limited, said, “The commissioning of UMC Hospital, Entebbe, reflects our continued focus on building resilient healthcare ecosystems in the regions we serve. This expansion is not just about increasing capacity—it is about deepening access to timely, high-quality care through a well-integrated network. By strengthening our hub-and-spoke model, we are ensuring that patients receive the right level of care at the right facility, supported by consistent clinical standards and coordinated pathways. As we scale our presence in Uganda, our priority remains clear: to deliver sustainable, patient-centric healthcare solutions that improve outcomes while maintaining operational efficiency.”

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.